EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers

Haruto Nishida iD, Takahiro Kusaba, Kazuhiro Kawamura, Yuzo Oyama, Tsutomu Daa

Cancers · 15.02.2023 · 15 (4) · 1236

DOI: 10.3390/cancers15041236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.02.2023. Verfasst von Haruto Nishida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Oita 879-5593, Japan. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salivary gland cancers (SGCs) are diagnosed using histopathological examination, which significantly contributes to their progression, including lymph node/distant metastasis or local recurrence. In the current World Health Organization (WHO) Classification of Head and Neck Tumors: Salivary Glands (5th edition), malignant and benign epithelial tumors are classified into 21 and 15 tumor types, respectively. All malignant tumors have the potential for lymph node/distant metastasis or local recurrence. In particular, mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma (AdCC), salivary duct carcinoma, salivary carcinoma, not otherwise specified (NOS, formerly known as adenocarcinoma, NOS), myoepithelial carcinoma, epithelial–myoepithelial carcinoma, and carcinoma ex pleomorphic adenoma (PA) are relatively prevalent. High-grade transformation is an important aspect of tumor progression in SGCs. MEC, AdCC, salivary carcinoma, and NOS have a distinct grading system; however, a universal histological grading system for SGCs has not yet been recommended. Conversely, PA is considered benign; nonetheless, it should be cautiously treated to avoid the development of metastasizing/recurrent PA. The aim of this review is to describe the current histopathological aspects of the prognostic factors for SGCs and discuss the genes or molecules used as diagnostic tools that might have treatment target potential in the future.

Schlagwörter

Stichwörter der Autor:innen

geneticshistopathologymoleculesprognostic factorssalivary gland cancers

Autor:innen und Institutionen

  • Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.

ORCID-Profile: Haruto Nishida

Zitieren

APA

Nishida, H., Kusaba, T., Kawamura, K., Oyama, Y., & Daa, T. (2023). Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers. Cancers, 15(4), 1236. https://doi.org/10.3390/cancers15041236

Vancouver

Nishida H, Kusaba T, Kawamura K, Oyama Y, Daa T. Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers. Cancers. 2023;15(4):1236. doi:10.3390/cancers15041236

BibTeX
@article{Nishida2023,
  author = {Nishida, Haruto and Kusaba, Takahiro and Kawamura, Kazuhiro and Oyama, Yuzo and Daa, Tsutomu},
  title = {Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1236},
  doi = {10.3390/cancers15041236}
}
Kostenlos starten →